This inventor holds 1 USPTO granted patent. Top assignee: Miltenyi Biotec B.v. & Co. Kg. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thorsten Olaf Hardt: Innovator in Cancer Treatment
Introduction
Thorsten Olaf Hardt is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Thorsten holds a patent titled "Compositions and Methods for Treating Cancer Expressing CD90 and CD326." This patent represents his commitment to advancing medical science and improving treatment options for cancer patients. He has 1 patent to his name.
Career Highlights
Thorsten is currently employed at Miltenyi Biotec B.V. & Co. KG, a company known for its focus on innovative biomedical solutions. His work at this organization has allowed him to contribute to groundbreaking research in the field of oncology.
Collaborations
Throughout his career, Thorsten has collaborated with talented individuals such as Christoph Herbel and Dominik Eckardt. These partnerships have fostered a collaborative environment that enhances the quality of research and innovation.
Conclusion
Thorsten Olaf Hardt is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. His contributions continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile